NPM1 and acute myeloid leukemia: Cytogenetic abnormalities can occur in 15% of NPM1-AML and, while globally, they did not show a significant impact [100], Angenendt et al. demonstrated that high-risk chromosomal abnormalities (3.4% of the cases) significantly and independently worsen prognosis, moving these cases into the adverse-risk category [101].